Federal Register / Vol. 87, No. 47 / Thursday, March 10, 2022 / Notices 13765 

(1) Organization name; 

(2) Organization type (e.g., non-profit or 

law firm); 

(3) Name and title of primary contact; 

(4) Primary contact mailing address, phone 

number, and email address; 

(5) Names and a brief description of 

relevant experience of principals and key 

staff; 

(6) Names and a brief description of 

relevant experience of the current governing 

board; 

(7) Brief description of how your 

organization will serve eligible veterans, 

dependents, or other persons with 

proceedings before the Court regardless of 

their location or residence; and 

(8) If the non-profit organization has not 

yet been established, names and a brief 

description of relevant experience of 

prospective members of a governing board. 

‘‘Relevant experience’’ includes 

experience with: (a) Veterans benefits 

law; (b) recruiting, training, supervising, 

and assigning cases to volunteer 

attorneys; (c) practice before the Court 

or supervision of attorneys practicing 

before the Court; (d) reviewing and 

evaluating veterans benefits cases; and 

(e) outreach and education for veterans 

and dependents regarding veterans 

benefits rights and procedures. 

The Pre-Application must not exceed 

seven (7) single-spaced pages and must 

be submitted as a single PDF document. 

D. Late or Incomplete Pre-Applications 

LSC may consider a request to submit 

a Pre-Application after the deadline, but 

only if the Applicant submitted an 

email to TaboasA@lsc.gov explaining 

the circumstances that caused the delay 

before the Pre-Application deadline. 

Communication with LSC staff is not a 

substitute for sending a formal request 

and explanation to TaboasA@lsc.gov. At 

its discretion, LSC may consider 

incomplete Pre-Applications. LSC will 

determine the admissibility of late or 

incomplete Pre-Application on a caseby-case basis. 

E. Additional Information and 

Guidelines 

Additional guidance and instructions 

on the Veterans Pro Bono Program PreApplication and Application processes 

will be available on https://lsc.gov/ 

grants/veterans-pro-bono-grantprogram. 

The Application, guidelines, content 

requirements, and specific selection 

criteria will be available the week of 

May 10, 2022, at www.lsc.gov. 

For more information about the 

current grantee, The Veterans 

Consortium Pro Bono Program, please 

visit www.vetsprobono.org. 

Authority: 42 U.S.C. 2996g(e). 

Dated: March 4, 2021. 

Stefanie Davis, 

Senior Associate General Counsel. 

[FR Doc. 2022–05031 Filed 3–9–22; 8:45 am] 

BILLING CODE 7050–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Meeting Notice 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) will convene a 

meeting of the Advisory Committee on 

the Medical Uses of Isotopes (ACMUI) 

on April 5, 2022. A sample of agenda 

items to be discussed during the public 

session includes: An overview of fiscal 

year (FY) 2021 medical related events; 

an overview of how to minimize 

institutional approaches to reducing 

medical events; an overview of two 

yttrium-90 microsphere technologies; an 

overview on non-medical events for FYs 

2020 and 2021; updates on the National 

Institute of Standards and Technology 

Radioisotope Measurement Assurance 

Program; a discussion on the current 

ACMUI reporting structure; and an 

update on Medical Team activities. The 

agenda is subject to change. The current 

agenda and any updates will be 

available on the ACMUI’s Meetings and 

Related Documents web page at https:// 

www.nrc.gov/reading-rm/doccollections/acmui/meetings/2022.html 

or by emailing Mr. Don Lowman at the 

contact information below. 

Purpose: Discuss issues related to 10 

CFR part 35 Medical Use of Byproduct 

Material. 

Date and Time for Open Session: 

Tuesday, April 5, 2022, from 10:00 a.m. 

to 5:00 p.m. EST. 

Date Webinar information 

(Microsoft Teams) 

April 5, 

2022.

Link: https://teams.microsoft.com/l/ 

meetup-join/19%3ameeting_

MzgyMWU5ZDUtMD

c2Ny00YmUwLWFkODUtND

k1N2Y5MmEzMTM2%40

thread.v2/0?context=

%7b%22Tid%22%3a%22e8

d01475-c3b5-436a-a065-5def

4c64f52e%22%2c%22Oid%22%

3a%2209a47f07-225c-402e-8b6f

-c9f03adf8db6%22%7d. 

Call in number (audio only): +1 

301–576–2978 (Silver Spring, 

MD, US). Phone Conference ID: 

220 765 08#. 

Public Participation: The meeting will 

be held as a webinar using Microsoft 

Teams. Any member of the public who 

wishes to participate in any open 

sessions of this meeting should click on 

the link above to join the meeting. It is 

recommended that attendees should 

login ten minutes prior to ensure they 

can properly connect to the meeting. 

Members of the public should also 

monitor the NRC’s Public Meeting 

Schedule at https://www.nrc.gov/pmns/ 

mtg for any meeting updates. If there are 

any questions regarding the meeting, 

persons should contact Mr. Lowman 

using the information below. 

Contact Information: Mr. Don 

Lowman, email: Donald.Lowman@

nrc.gov, telephone: 301–415–5452. 

Conduct of the Meeting 

The ACMUI Chair, Darlene F. Metter, 

M.D., will preside over the meeting. Dr. 

Metter will conduct the meeting in a 

manner that will facilitate the orderly 

conduct of business. The following 

procedures apply to public participation 

in the meeting: 

1. Persons who wish to provide a 

written statement should submit an 

electronic copy to Mr. Lowman using 

the contact information listed above. All 

submittals must be received by the close 

of business on March 28, 2022 and must 

only pertain to the topics on the agenda. 

2. Questions and comments from 

members of the public will be permitted 

during the meeting, at the discretion of 

the ACMUI Chairman. 

3. The draft transcript and meeting 

summary will be available on ACMUI’s 

website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 

2022.html on or about May 17, 2022. 

4. Persons who require special 

services, such as those for the hearing 

impaired, should notify Mr. Lowman of 

their planned participation. 

This meeting will be held in 

accordance with the Atomic Energy Act 

of 1954, as amended (primarily Section 

161a); the Federal Advisory Committee 

Act (5 U.S.C. App); and the 

Commission’s regulations in title 10 of 

the Code of Federal Regulations, Part 7. 

Dated at Rockville, Maryland this 7th day 

of March, 2022. 

For the U.S. Nuclear Regulatory 

Commission. 

Russell E. Chazell, 

Federal Advisory Committee Management 

Officer. 

[FR Doc. 2022–05047 Filed 3–9–22; 8:45 am] 

BILLING CODE 7590–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES